Concerns mounted after the failure of Wainua, an approved treatment for rare neurological disorder ATTR-CM, in a Phase III ...
When it releases second-quarter earnings on Monday, analysts and investors say they will be focusing less on the numbers and ...
U.S. stocks fell sharply as global oil prices topped $100 a barrel for the first time in two months and earnings from Alphabet and Tesla rekindled AI spending fears. Rising oil prices helped push the ...